MST1 and diabetic cardiomyopathy: In a diabetic cardiomyopathy mouse model [29], endogenous activation of melatonin may hamper the progression of diabetic cardiomyopathy by up-regulating cardiomyocyte autophagy through Mst1 inhibition.